Welcome

United States Chronic Obstructive Pulmonary Disease Drug Markets

 

  • Research Code : 5913-01-00-00-00
  • SKU : HC00291-NA-MR_03314
  • Share this :
  • Release Date : 15-Jun-1999
  • Region : North America
  • Request Study Sample

Availability: In stock

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

Pay By Invoice

Be the first to review this product



Table of Contents

United States Chronic Obstructive Pulmonary Disease Drug Markets, Executive Summary

Introduction to the COPD Drug Therapy Market

Objectives and Purpose
Report Scope and Segmentation
Report Structure
Patient Population Statistics

Summary of Major Findings

Total Revenues and Revenue Growth Rates
Analysis by Major Segment
Competitive Analysis

United States Chronic Obstructive Pulmonary Disease Drug Markets, Market Engineering Research Methodology

Frost & Sullivan's Market Engineering Forecasting Methodology for the Pharmaceutical Industry

Frost & Sullivan's Market Engineering Forecasting Methodology for the Pharmaceutical Industry

Research Sources

Secondary Sources
Primary Research

Industry Specific Forecast Model

Industry Specific Forecast Model
Population-Based Forecast
Product-Based Forecast
Market Model Assumptions

Presentation of Market Engineering Measurements, Definition and their Strategic Significance

Presentation of Market Engineering Measurements, Definition and their Strategic Significance

Glossary of Terms

List of Acronyms
List of Definitions

United States Chronic Obstructive Pulmonary Disease Drug Markets, Challenges in the COPD Drug Therapy Market

Introduction

Introduction
Diversity of Providers Limits Targeted Marketing Campaigns
Poor Diagnostic Capability Retards Revenue Growth
Lack of Understanding of Disease Pathology Deters Development of Curative Treatments
Developing Curative Treatment Initiates Market Expansion
Low Product Penetration Rates Plummet Market Growth
Usage of Generic Names When Prescribing Erodes Brand Name Recognition
"Trial-and-Error" Treatment Protocols Lower Product Acceptance
Treating a Geriatric Patient Population Challenges Market Participants
Conversion of Delivery Technology from Asthma to COPD Propels R&D
Keeping Ahead of Competition Determines Market Leaders

Market Engineering Research for the Existing U.S. COPD Drug Therapies Market 1994-2004

Total Market Analysis

Market Overview and Definitions
Disease Overview
Disease Population Estimates and Trends
Current Treatment Pathways
Drug Delivery Systems
Market Engineering Research Measurement System
Market Engineering Revenue Forecasts (1994-2004)

Market Engineering Estimates for Bronchodilator COPD Drug Therapy Market

Market Overview and Definitions
Market Engineering Research Measurement System
Market Drivers
Market Restraints
Market Engineering Revenue Forecasts (1994-2004)
Competitive Analysis
Product Analysis

Market Engineering Estimates for Inhaled Corticosteroid COPD Therapy Market

Market Overview and Definitions
Market Engineering Research Measurement System
Market Drivers
Market Restraints
Market Engineering Revenue Forecasts (1994-2004)
Competitive Analysis
Product Analysis

United States Chronic Obstructive Pulmonary Disease Drug Markets, U.S. Emerging COPD Therapy Market 1998-2004

Introduction

Introduction

Research Focus in Symptom Management

Research Focus in Symptom Management
Bronchodilators
Anti-Inflammatory/Corticosteroid Drugs
Mucus Expectorants

Research Focus in Reversing Lung Damage

Overview
Gene Therapy
Immunotherapy
Proteinase Inhibitors

Products In the Pipeline

Products In the Pipeline
HP-3 (Milkhaus Laboratory)
Ariflo (SmithKline Beecham)
AAT Deficiency Emphysema Gene Replacement Therapy (Gene Medicine)
ZD0892 (Zeneca)
GW311616 (Glaxo Wellcome)
SB223412 (SmithKline Beecham)

United States Chronic Obstructive Pulmonary Disease Drug Markets, Market Engineering Strategy

Market Engineering Strategic Recommendations

Market Engineering Strategic Recommendations
Marketing Department
Research and Development Department
Sales Department
Business Development Department
Corporate Management


Sample Study






Related Research
WHY CHOOSE
FROST & SULLIVAN
RESEARCH ?

1. Primary Research

Our analysis is based on comprehensive primary research conducted with core market participants.

2. Global Coverage

Unparalleled coverage of geographies, our analyst & consultant teams are based in 42+ offices spanning the globe.

3. Breadth of Vertical Industries

We cover the broadest spectrum of markets to provide our clients with the most relevant analysis and transformational insights.

4. Visionary Innovation Research

With on-going transformational shifts, our visionary innovation research prepares you with information on key megatrends shaping the future of your industry.

5. Mega Trends

Mega Trends are global forces that transform business, societies and economies.

6. Convergence Research Coverage

Taking an approach of analysing a macro-to-micro impact, our convergence research helps you prepare against an impending 'Kodak moment'.